Special Populations

ACC overview

Special populations in adrenocortical carcinoma (ACC) include clinical contexts in which the disease differs meaningfully from the usual adult sporadic presentation, such as pediatric tumors, hereditary cancer predisposition syndromes, pregnancy-associated diagnosis, fertility and teratogenicity questions, and rare hormonal or extra-adrenal presentations. Within ACC care, these groups are important because they may alter pretest probability, endocrine phenotype, counseling needs, surveillance strategies, and treatment constraints. At the same time, the evidence base is limited: much of the literature for uncommon presentations is retrospective, anecdotal, or extrapolated from broader endocrine oncology rather than derived from ACC-specific comparative studies.¹²³

The special-population literature is also uneven. Pediatric and hereditary settings generally have clearer biological relevance to ACC, whereas many reports on unusual endocrine states or comparative pathology provide only indirect context. Rare presentations may broaden differential diagnosis and generate mechanistic hypotheses, but they do not usually establish management standards on their own.¹² In practice, these populations are typically interpreted alongside standard ACC workflows for staging, endocrine evaluation, surgery, and systemic therapy rather than as separate evidence systems.

A further limitation is that some material historically cited around “special populations” does not directly inform human ACC care. Older endocrine reports and veterinary case literature may illustrate general principles about adrenal hormone biology, comparative oncology, or the possibility of multiple endocrine neoplasms, but their generalizability to human ACC diagnosis, prognosis, and treatment is weak.¹²³ Their main value is contextual rather than directive.

Diagnostic and Clinical Context

Special-population framing is most relevant when ACC presents in ways that change baseline suspicion or complicate standard decision-making. In children and in patients with known hereditary syndromes, the threshold for considering adrenal cortical malignancy may differ from that in typical adult incidentaloma pathways. In pregnancy or fertility planning, treatment timing and drug safety become central concerns, while rare secretory or ectopic presentations may obscure the diagnosis by mimicking other endocrine disorders.

What is reliable is the general principle that these contexts may modify presentation and management priorities. What is less reliable is any attempt to infer population-level outcomes from isolated case material, particularly when evidence comes from historical reports or nonhuman pathology.¹² Clinically, special-population status should therefore prompt tailored multidisciplinary review rather than confidence based on sparse precedent.

Major Special-Population Phenotypes

Pediatric and childhood disease

Pediatric ACC represents the most established special-population category because it differs from adult disease in age distribution, endocrine activity, inherited predisposition patterns, and treatment context. Childhood tumors are often discussed separately from adult ACC because prognosis, biologic associations, and operative considerations may not align with the usual adult sporadic paradigm.

This is one of the more clinically meaningful special-population groupings, but even here the literature is dominated by uncommon-disease series rather than large prospective studies. The practical implication is that pediatric cases are usually interpreted through dedicated pediatric endocrine-oncology and surgical frameworks, with adult ACC data used cautiously when direct pediatric evidence is lacking.

Grouped note: Pediatric ACC and Childhood Adrenocortical Tumors

Hereditary and syndromic ACC

A subset of ACC arises in hereditary cancer predisposition or overgrowth syndromes, including settings in which surveillance, family counseling, and germline testing become central parts of care. These syndromic contexts are relevant not only because they may increase risk, but also because they can shift the diagnostic frame from an isolated adrenal malignancy to a familial cancer syndrome with implications for relatives and for screening of other tumors.

The reliable conclusion is that hereditary context matters clinically when suspicion is present, especially in younger patients or those with suggestive family histories. What remains less certain is the exact magnitude of risk or the optimal syndrome-specific surveillance strategy across all rare syndromic associations, because many reports are based on small cohorts or aggregated case experience. In practice, these cases usually warrant genetics-informed management rather than reliance on tumor-directed evidence alone.

Grouped note: Hereditary and Syndromic ACC

Pregnancy, fertility, and reproductive contexts

ACC diagnosed during pregnancy or in patients considering fertility introduces competing maternal, fetal, oncologic, and endocrine priorities. These cases are uncommon, but they are clinically important because hormonal excess may affect both mother and fetus, diagnostic imaging options may be constrained, and systemic therapies such as mitotane raise teratogenicity concerns.

The broad principle that reproductive context can substantially alter management is well accepted, whereas detailed treatment recommendations are supported mainly by limited case-based evidence. The practical implication is that standard ACC treatment goals remain relevant, but timing and therapeutic choice often require individualized discussion among endocrine, oncology, surgical, and maternal-fetal specialists.

Grouped note: Pregnancy, Fertility, and Reproductive Contexts in ACC

Unusual hormonal and ectopic presentations

Some ACCs present with uncommon secretory phenotypes or in anatomically unusual locations, including tumors associated with atypical hormone syndromes or extra-adrenal cortical tissue. These presentations are important because they may delay recognition of ACC or broaden the differential diagnosis to include other adrenal, neuroendocrine, or metastatic processes.

Here the evidence is especially vulnerable to publication bias, since rare and dramatic presentations are more likely to be reported than typical ones. The clinical implication is that such cases may help clinicians recognize diagnostic possibilities, but they should not be used to estimate frequency, prognosis, or treatment effect with confidence.

Grouped note: Unusual Hormonal and Ectopic Presentations of ACC

Indirect, Historical, and Comparative Evidence

Because special populations are rare, the literature sometimes incorporates reports that are only indirectly related to human ACC. Historical endocrine papers may reflect earlier ideas about hormone-dependent carcinogenesis, and veterinary pathology reports may show that adrenal cortical carcinoma can occur within broader endocrine syndromes or alongside other primary tumors in nonhuman species.¹²³

These sources are most reliable as background on endocrine biology and comparative oncology, not as evidence for human ACC management. A historical case after bilateral adrenalectomy chiefly illustrates caution in making broad causal claims about endocrine states and carcinogenesis, while veterinary reports in a ferret and a dog mainly underscore indirect comparative themes such as species-specific endocrine syndromes and multiple primary neoplasms.¹²³ In practical terms, such material may be useful for context but should not outweigh human clinical data when making diagnostic or treatment decisions.

Role in Management and Research

Across special populations, the main contribution of the literature is to identify situations in which standard ACC pathways need adaptation rather than replacement. Pediatric age, hereditary predisposition, pregnancy, and unusual secretory or anatomic presentations may all justify broader endocrine testing, earlier genetics input, modified imaging or treatment planning, and closer multidisciplinary coordination.

What is dependable is the need for individualized care in these settings. What remains uncertain is how far management should diverge from standard adult ACC algorithms in the absence of stronger comparative evidence. For researchers, this makes special populations an area where registry-based studies, collaborative cohorts, and standardized reporting are likely to be more informative than further isolated case reports, especially for questions of prognosis, surveillance, fertility outcomes, and syndrome-specific management.

Included Articles

• PMID 13345873: A 1956 case report on breast carcinoma developing after bilateral adrenalectomy and chronic adrenal insufficiency is only indirectly relevant to ACC. It mainly illustrates historical caution about broad endocrine causation claims rather than providing ACC-specific evidence.¹

• PMID 20446034: PMID 20446034 is a veterinary case report describing adrenal cortical carcinoma in a ferret with hyperadrenocorticism, type 1 diabetes mellitus, and chronic pancreatitis. Its relevance to ACC is indirect and comparative rather than clinically actionable for human disease.²

• PMID 25587729: PMID 25587729 is a veterinary pathology case report describing concurrent adrenal cortical carcinoma and mediastinal thyroid follicular carcinoma in a dog. Its relevance to ACC is indirect, mainly as comparative background on multiple endocrine neoplasms rather than evidence for human ACC care.³

References

Footnotes

1. Chronic adrenocortical insufficiency and carcinoma of the breast.. J Clin Endocrinol Metab. 1956. PMID: 13345873. Local full text: 13345873.md ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷

2. Type 1 diabetes mellitus and hyperadrenocorticism in a ferret.. Vet Res Commun. 2010. PMID: 20446034. Local full text: 20446034.md ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷

3. Pathology in practice. Mediastinal thyroid follicular carcinoma and adrenal carcinoma.. J Am Vet Med Assoc. 2015. PMID: 25587729. Local full text: 25587729.md ↩ ↩² ↩³ ↩⁴ ↩⁵